Amgen's net income falls but earnings per share up

You are here: Home > Central Coast Health Watch > Current Article

Amgen’s net income falls but earnings per share up

By Staff Report / Tuesday, October 30th, 2018 / Comments Off on Amgen’s net income falls but earnings per share up

Net income for Thousand Oaks biotech giant Amgen fell 8 percent for the third quarter to $1.86 billion, but revenue and earnings per share both saw an uptick, spurred by strong new product sales and share buybacks. Product sales increased 1 percent overall compared to the same period the prior year, the company reported Oct.…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.